Target intelligence / Profile preview

PET100 pseudogene 1 (PET100P1)

Target
PET100P1
Molecular classification
Pseudogene, Non-coding RNA (potential), Other
01

Overview

PET100 pseudogene 1 (PET100P1) is a **pseudogene** related to the functional gene PET100, which encodes a chaperone involved in the biogenesis of mitochondrial complex IV, cytochrome c oxidase. Pseudogenes like PET100P1 are genomic regions that originate from functional genes but typically lack protein-coding capacity due to mutations, truncations, or other alterations[1][2][3][4]. The primary PET100 gene is located on chromosome 19; PET100P1 is typically described as a non-functional copy located on chromosome 3[1][3]. Pseudogenes often do not produce a functional protein and are generally not considered druggable or therapeutic targets themselves[2][4]. However, in some cases, selected pseudogenes can exert regulatory influences (such as through non-coding RNA functions or by acting as competing endogenous RNAs), but there is currently no evidence PET100P1 has such a role[2][4][5]. No known drugs, clinical biomarkers, therapeutic mechanisms, or disease associations specific to PET100P1 exist. The inclusion of “pseudogene” in the name and lack of protein-coding evidence suggest PET100P1 is **not a therapeutic target** and would generally not be referenced as such in biomedical research. If the intention was to refer to the functional protein-coding PET100 gene, the correct canonical name would be “PET100 cytochrome c oxidase chaperone” (abbreviation: PET100)[1][3].

Other names
PET100P1PET100 pseudogenePET100P
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on PET100 pseudogene 1 (PET100P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PET100 pseudogene 1 (PET100P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call